REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 689-698

  Rafa, Louisa ^a,b,c   Dessein, Anne Frédérique ^a,b,c   Devisme, Louise ^c   Buob, David ^c   Truant, Stéphanie ^a,b,c   Porchet, Nicole ^a,b,c   Huet, Guillemette ^a,b,c   Buisine, Marie Pierre ^a,b,c   Lesuffleur, Thécla ^a,d,e  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

Colorectal carcinomas; Fetal intestine; Migration and invasion; Proliferation; Regenerating islet derived 4

Indexed keywords

ANTIBODY; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; REGENERATING 4 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; COLLAGEN; LECTIN; MITOGENIC AGENT; REG4 PROTEIN, HUMAN;

ARTICLE; AUTOCRINE EFFECT; BIOLOGY; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; EMBRYO; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; BIOSYNTHESIS; CELL MOTION; CHEMISTRY; COLON; COLON TUMOR; DISEASE COURSE; EMBRYOLOGY; EPITHELIUM; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; WOUND HEALING;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; COLON; COLONIC NEOPLASMS; DISEASE PROGRESSION; EPITHELIUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LECTINS, C-TYPE; MITOGENS; NEOPLASM INVASIVENESS; WOUND HEALING;

EID: 77149158125     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000544     Document Type: Article

References (37)

1. Iovanna JL and Dagorn JC: The multifunctional family of secreted proteins containing a C-type lectin-like domain linked to a short N-terminal peptide. Biochim Biophys Acta 1723: 8-18, 2005.
2. Okamoto H: The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells. J Hepatobiliary Pancreat Surg 6: 254-262, 1999.
3. Hartupee JC, Zhang H, Bonaldo MF, Soares MB and Dieckgraefe BK: Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 1518: 287-293, 2001.
4. Kamarainen M, Heiskala K, Knuutila S, Heiskala M, Winqvist O and Andersson LC: RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am J Pathol 163: 11-20, 2003.
5. Nanakin A, Fukui H, Fujii S, Sekikawa A, Kanda N, Hisatsune H, Seno H, Konda Y, Fujimori T and Chiba T: Expression of the REG IV gene in ulcerative colitis. Lab Invest 87: 304-314, 2007.
6. Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M and Lesuffleur T: Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 103: 185-193, 2003.
7. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H and Yasui W: Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 207: 185-198, 2005.
8. Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M and Reiter RE: Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res 11: 2237-2243, 2005.
9. Bishnupuri KS, Luo Q, Korzenik JR, Henderson JO, Houchen CW, Anant S and Dieckgraefe BK: Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther 5: 1714-1720, 2006.
10. Mitani Y, Oue N, Matsumura S, Yoshida K, Noguchi T, Ito M, Tanaka S, Kuniyasu H, Kamata N and Yasui W: Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 26: 4383-4393, 2007.
11. Oue N, Kuniyasu H, Noguchi T, Sentani K, Ito M, Tanaka S, Setoyama T, Sakakura C, Natsugoe S and Yasui W: Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 72: 371-380, 2007.
12. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S and Dieckgraefe BK: Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 130: 137-149, 2006.
13. Leteurtre E, Gouyer V, Rousseau K, Moreau O, Barbat A, Swallow D, Huet G and Lesuffleur T: Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate. Biol Cell 96: 145-151, 2004.
14. Lesuffleur T, Violette S, Vasile-Pandrea I, Dussaulx E, Barbat A, Muleris M and Zweibaum A: Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype. Int J Cancer 76: 383-392, 1998.
15. Lesuffleur T, Barbat A, Dussaulx E and Zweibaum A: Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50: 6334-6343, 1990.
16. Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B and Zweibaum A: Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int J Cancer 49: 721-730, 1991.
17. Truant S, Bruyneel E, Gouyer V, De Wever O, Pruvot FR, Mareel M and Huet G: Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells. Int J Cancer 104: 683-694, 2003.
18. Gouyer V, Fontaine D, Dumont P, et al: Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene 27: 4024-4033, 2008.
19. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL and Rousset M: Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122: 21-29, 1985.
20. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A and Rousset M: Differential expression of sucraseisomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107: 213-225, 1994.
21. Dignass A, Lynch-Devaney K, Kindon H, Thim L and Podolsky DK: Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 94: 376-383, 1994.
22. Toback FG, Walsh-Reitz MM, Musch MW, Chang EB, Del Valle J, Ren H, Huang E and Martin TE: Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein, are mitogenic and motogenic. Am J Physiol Gastrointest Liver Physiol 285: G344-G353, 2003.
23. Bracke M, Boterberg T and Mareel M: Collagen invasion assay, chick heart invasion assay. In: Metastasis Methods and Protocols. Humana Press, Totowa, 2000.
24. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N and Aubert JP: Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 49: 544-551, 2001.
25. Hovenberg HW, Davies JR, Herrmann A, Linden CJ and Carlstedt I: MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 13: 839-847, 1996.
26. Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T and Esumi H: ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol 24: 3526-3535, 2004.
27. Christa L, Carnot F, Simon MT, Levavasseur F, Stinnakre MG, Lasserre C, Thepot D, Clement B, Devinoy E and Brechot C: HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol 271: G993-G1002, 1996.
28. Valery C, Vasseur S, Sabatier F, Iovanna JL, Dagorn JC, Grob JJ and Verrando P: Pancreatitis associated protein I (PAP-I) alters adhesion and motility of human melanocytes and melanoma cells. J Invest Dermatol 116: 426-433, 2001.
29. Ose T, Kadowaki Y, Fukuhara H, Kazumori H, Ishihara S, Udagawa J, Otani H, Takasawa S, Okamoto H and Kinoshita Y: Reg I-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine. Oncogene 26: 349-359, 2007.
30. Wright NA, Pike C and Elia G: Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343: 82-85, 1990.
31. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A and Atomi Y: Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84: 1317-1321, 2001.
32. Kuniyasu H, Oue N, Sasahira T, Yi L, Moriwaka Y, Shimomoto T, Fujii K, Ohmori H and Yasui W: Reg IV enhances peritoneal metastasis in gastric carcinomas. Cell Prolif 42: 110-121, 2009.
33. Glebov OK, Rodriguez LM, Soballe P, DeNobile J, Cliatt J, Nakahara K and Kirsch IR: Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa. Cancer Epidemiol Biomarkers Prev 15: 2253-2262, 2006.
34. Schroder N, Sekhar A, Geffers I, Muller J, Dittrich-Breiholz O, Kracht M, Wedemeyer J and Gossler A: Identification of mouse genes with highly specific expression patterns in differentiated intestinal epithelium. Gastroenterology 130: 902-907, 2006.
35. Macadam RC, Sarela AI, Farmery SM, Robinson PA, Markham AF and Guillou PJ: Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family. Br J Cancer 83: 188-195, 2000.
36. Nishimune H, Vasseur S, Wiese S, Birling MC, Holtmann B, Sendtner M, Iovanna JL and Henderson CE: Reg-2 is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF survival pathway. Nat Cell Biol 2: 906-914, 2000.
37. Sekikawa A, Fukui H, Fujii S, Takeda J, Nanakin A, Hisatsune H, Seno H, Takasawa S, Okamoto H, Fujimori T and Chiba T: REG Ialpha protein may function as a trophic and/or antiapoptotic factor in the development of gastric cancer. Gastroenterology 128: 642-653, 2005.